-
partners, thereby ensuring that all DCs will spend time in both academia and industry. The details of each project description and further instructions on How to Apply for them can be found at https
-
duration of 3 years, starting in Summer 2026. Objective of the project: Finnadvance is an organ-on-chip company that has developed the AKITA microfluidic platform. It elicits the generation of biological
Enter an email to receive alerts for microfluidics "https:" positions